Effectiveness of Yoga on Ambulatory Blood Pressure in Patients With Pre- and Stage I Hypertension
NCT ID: NCT01542359
Last Updated: 2013-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2011-09-30
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Yoga in Altering Mechanistic Outcomes in Hypertension
NCT05158205
Acute Effects of Vinyasa Yoga on Vascular Function
NCT04226235
Effects of Yoga on Sodium-induced Pressor Responses in African American Adults
NCT05353270
Yoga as a Supportive Therapy for Patients With Hypertension
NCT02727140
Yoga for a Healthy Heart
NCT06155240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Yoga
The integrated yoga program was designed to: 1) include the three primary elements of yoga as most commonly practiced in western cultures (physical postures, breath control and meditation); and 2) be appropriate for those without any prior yoga experience and with pre- and Stage I hypertension. The yoga program was designed by Eddie Stern, Founder and Director of "Ashtanga Yoga New York" (AYNY) in consultation with Drs. Hagins and Rundle, and are in large part congruent with the yoga program we studied previously (see Preliminary Studies). The yoga class includes: instruction on yogic principles regarding moral precepts (yamas and niyamas); active postures requiring mild-moderate physical exertion; conscious control of the breath in synchrony with active postures; and meditation. We expect approximately 10-15 minutes of the integrated yoga program to consist of isolated practice of meditation (occurring independently of the moving postures, typically in seated or lying positions).
Yogic practice
breathing, meditation, physical postures
Conventional Exercise
Conventional exercise such as standing toe touch with arm swings, curl ups, push ups, leg lifts, etc. All done at a relatively slow rate which will be non-aerobic and at an average rate across the session of 3 METs
Conventional Exercise
Standard physical exercises such as toe touch in standing, curl ups, push ups, leg lifts
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conventional Exercise
Standard physical exercises such as toe touch in standing, curl ups, push ups, leg lifts
Yogic practice
breathing, meditation, physical postures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Medically stable on any current medications; BMI (kg/m2) between 18.5 - 40
* English speaking
Exclusion Criteria
* Previous cardiovascular event (prior myocardial infarction, stroke, or angina pectoris)
* Current or previous cancer diagnosis
* Congestive heart failure
* History of kidney disease
* Signs or symptoms of significant peripheral vascular disease
* Significant co-morbidities that preclude successful completion of the study
* Yoga practitioner (participated in more than 3 yoga sessions within the last year)
21 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Long Island University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marshall Hagins
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marshall A Hagins, PhD, PT
Role: PRINCIPAL_INVESTIGATOR
Long Island University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Long Island University
Brooklyn, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1SC3GM088049-01A1 REVISED
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.